1α,25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer

被引:109
|
作者
Nakagawa, K
Kawaura, A
Kato, S
Takeda, E
Okano, T
机构
[1] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan
[3] Univ Tokushima, Sch Med, Dept Clin Nutr, Tokushima, Japan
关键词
D O I
10.1093/carcin/bgh332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1alpha,25-Dihydroxyvitamin D-3 [1alpha,25(OH)(2)D-3], the major regulator of calcium homeostasis, has potent antiproliferative and anti-invasive properties in vitro in cancer cells. Studies in vivo demonstrated that 1alpha,25(OH)(2)D-3 slows the progression of breast, prostate and other carcinomas. A key question is whether 1alpha,25(OH)(2)D-3 exerts its anticarcinogenic effects in vivo by a mechanism that is dependent on its capacity to limit the proliferation and invasiveness of cancer cells in vitro. It has not been clear whether the calcemic activity and regulation of the host defenses by 1alpha,25(OH)(2)D-3 contribute to the effect on cancer cells. In this study we have focused on the influence of 1alpha,25(OH)(2)D-3 on the metastasis of lung cancer, without involvement of the calcemic activity and other effects of 1alpha,25(OH)(2)D-3 in the host. We used metastatic Lewis lung carcinoma cells expressing green fluorescent protein (LLC-GFP cells) and examined metastatic activity in vitamin D receptor (VDR) null mutant (VDR-/-) mice and their wild-type counterparts (VDR+/+ mice). VDR-/- mice exhibit hypocalcemia and extremely high serum levels of 1alpha,25(OH)(2)D-3. We expected that serum 1alpha,25(OH)(2)D-3 would act in vivo to directly inhibit the metastatic growth of VDR-positive LLC-GFP cells in VDR-/- mice. The metastatic activities of LLC-GFP cells were remarkably reduced in VDR-/- mice compared with VDR+/+ mice. To test the hypothesis that serum 1alpha,25(OH)(2)D-3 is an intrinsic factor that inhibits metastatic growth of lung cancer cells, we corrected hypocalcemia and/or hypervitaminosis D in VDR-/- mice by dietary manipulation. The metastatic growth of LLC-GFP cells was remarkably reduced in response to serum levels of 1alpha,25(OH)(2)D-3, but not to serum calcium levels. Furthermore, we found that VDR+/+ mice fed the manipulated diets displayed an apparent inverse relationship between the physiological levels of serum 1alpha,25(OH)(2)D-3 (8-15 pg/ml) and tumorigenesis. Here we show that 1alpha,25(OH)(2)D-3 inhibits the metastatic growth of lung cancer cells in a defined animal model.
引用
收藏
页码:429 / 440
页数:12
相关论文
共 50 条
  • [21] Osteoblast responsiveness to 1α,25-dihydroxyvitamin D3 during spaceflight
    Kumei, Y
    Morita, S
    Nakamura, H
    Katano, H
    Ohya, K
    Shimokawa, H
    Sams, CF
    Whitson, PA
    SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 : 121 - 124
  • [22] 1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo
    Mantell, DJ
    Owens, PE
    Bundred, NJ
    Mawer, EB
    Canfield, AE
    CIRCULATION RESEARCH, 2000, 87 (03) : 214 - 220
  • [23] REGULATION OF CYSTATHIONINE BETA SYNTHASE BY 1α,25-DIHYDROXYVITAMIN D3
    Kriebitzsch, Carsten
    Verlinden, Lieve
    Eelen, Guy
    Marchal, Kathleen
    DeMoor, Bart
    Beullens, Ine
    Van Camp, Mark
    Bouillon, Roger
    Verstuyf, Annemieke
    BONE, 2010, 46 : S51 - S51
  • [24] 1 alpha,25-dihydroxyvitamin D3 stimulates keratinocyte proliferation
    Patria, F.
    Ceccarini, M.
    Codini, M.
    Conte, C.
    Cataldi, S.
    Beccari, T.
    Albi, E.
    JOURNAL OF BIOTECHNOLOGY, 2019, 305 : S71 - S71
  • [25] Effect of 1α,25-dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo
    David D. Dean
    Barbara D. Boyan
    Zvi Schwartz
    Ofelia E. Muniz
    Manuel R. Carreno
    Shingo Maeda
    David S. Howell
    Endocrine, 2001, 14 : 311 - 323
  • [26] 1α,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells
    Tse, Anfernee Kai-Wing
    Zhu, Guo-Yuan
    Wan, Chi-Keung
    Shen, Xiao-Ling
    Yu, Zhi-Ling
    Fong, Wang-Fun
    MOLECULAR IMMUNOLOGY, 2010, 47 (09) : 1728 - 1738
  • [27] Effect of 1α,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo
    Dean, DD
    Boyan, BD
    Schwartz, Z
    Muniz, OE
    Carreno, MR
    Maeda, S
    Howell, DS
    ENDOCRINE, 2001, 14 (03) : 311 - 323
  • [28] Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3
    Hsu, Jong-Wei
    Yasmin-Karim, Sayeda
    King, Michael R.
    Wojciechowski, Joel C.
    Mickelsen, Deanne
    Blair, Martha L.
    Ting, Huei-Ju
    Ma, Wen-Lung
    Lee, Yi-Fen
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (02): : 872 - 880
  • [29] 1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells
    Bessler, Hanna
    Djaldetti, Meir
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) : 428 - 432
  • [30] Calcitrol (1α,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells
    Kaeding, Jenny
    Belanger, Julie
    Caron, Patrick
    Verreault, Melanie
    Belanger, Alain
    Barbier, Olivier
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (02) : 380 - 390